F
MENA Analytica
Libya
๐Ÿ“กRegulatory Feed๐Ÿ“šLegal Library๐Ÿ—‚Sector Topics
Live
Sign in
โ† Back to Recent Changes
Neutraldecision๐Ÿ‘ Monitor

Decision No. 249 of 2023: Adoption of Medical Treatment Abroad Committee Minutes

31-05-2023ยทุฑุฆูŠุณ ู…ุฌู„ุณ ุงู„ูˆุฒุฑุงุกยทุงู„ุนู…ู„ ูˆุงู„ุชูˆุธูŠู
Analysis
Summary

The Prime Minister formally adopts the minutes of the third meeting of a committee established to review and approve outstanding debts for medical treatment received abroad. The decision references the committee's establishment under PM Decision No. 262 of 2021 and makes the minutes effective immediately upon issuance.

Business Implication

This decision has minimal direct impact on foreign investors or companies unless they are healthcare providers or insurers involved in medical treatment abroad programs. The adoption of committee minutes regarding debt review suggests the government is attempting to resolve legacy liabilities in the medical sector, which could eventually affect healthcare companies with outstanding receivables from Libyan entities. Companies in the medical evacuation or cross-border healthcare services sector should monitor whether debt resolution creates payment opportunities or sets precedents for settling arrears.

Key Provisions
Formal adoption of third meeting minutes from committee established under PM Decision 262/2021
Committee mandate focuses on reviewing and approving medical treatment abroad debts
Decision takes immediate effect from date of issuance (31 May 2023)
View original source โ†—
Expert Commentary

No expert commentary yet on this document.

Ask about this document

Ask any question about this document โ€” answered from the full Libyan regulatory corpus

Upgrade to use Q&A โ†’